Most Recent

  • 13 May 2013

The Global Financial Community Seeks More

Our new white paper tells you how –and where - to find it

  • 14 Mar 2013

Solving for Symbology Discord

A new white paper on the challenges of identity and their importance to the financial industry

  • 21 Feb 2013

Navigate the Complex Litigation Landscape with Hosted Practice Technology

New white paper discusses top issues facing litigation managers today

Recommended

Market Abuse Regulation of the Commodities and Energy Markets

This research paper identifies and summarises the existing and future regulations that continue to tighten the obligations of firms operating in the Commodities and Energy markets in the US and Europe.

Who's Making the Biggest Splash?

Expert, measured insight into organizations that helped to shape professional opinions on drugs and therapies, using the unique insights of the Thomson Reuters Medical Literature AnalyzerSM.

Recommended

Most Recent

  • 13 May 2013

The Global Financial Community Seeks More

Our new white paper tells you how –and where - to find it

  • 14 Mar 2013

Solving for Symbology Discord

A new white paper on the challenges of identity and their importance to the financial industry

Recommended

Market Abuse Regulation of the Commodities and Energy Markets

This research paper identifies and summarises the existing and future regulations that continue to tighten the obligations of firms operating in the Commodities and Energy markets in the US and Europe.

Most Recent

  • 13 Mar 2011

Newport Whitepapers

Our latest white papers from Newport on Deals, Biologics, Japanese Generics and 5 Myths.

  • 07 Mar 2011

New Study on Scientific Progress in Middle East

Turkey, Iran, Egypt, Saudi Arabia and Jordan currently account for 90 percent of the region's output.

  • 16 Nov 2010

High-Risk, High-Reward

Our new report on Asia Pacific Pharma companies' R&D activity.

  • 12 Aug 2009

Outlook and Issues for the Biotechnology Sector

A comprehensive assessment of Wall Street’s perception of and outlook for the biotechnology sector. This analysis aims to provide companies with an insider’s perspective on what the investment community values in the current economic climate, including cash position, pipeline, regulatory environment, upcoming catalysts, and IR communications, among others.

Recommended

Who's Making the Biggest Splash?

Expert, measured insight into organizations that helped to shape professional opinions on drugs and therapies, using the unique insights of the Thomson Reuters Medical Literature AnalyzerSM.